Today in News History

On July 12, several notable moments in the history of News stand out. In 1730, Josiah Wedgwood, English potter, founded the Wedgwood Company (died 1795) was born. In 1849, William Osler, Canadian physician and author (died 1919) was born. In 1923, James E. Gunn, American science fiction author (died 2020) was born. In 1925, Roger Smith, American businessman (died 2007) was born. In 1933, Victor Poor, American engineer, developed the Datapoint 2200 (died 2012) was born. In 1933, Donald E. Westlake, American author and screenwriter (died 2008) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1948, Richard Simmons, American fitness trainer and actor (died 2024) was born. In 1996, Jordan Romero, American mountaineer was born. In 2024, Evan Wright, American writer (born 1964) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?

The Motley Fool

The Motley Fool

·

July 7, 2026

·

lean left

One has FDA approval and revenue; the other is pre-commercial but debt-free. Both face distinct risks that could reshape your biotech bet.

Narrative Intelligence Brief

This article was published by The Motley Fool, a source frequently categorized with a lean left bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The Motley Fool, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 2 related reports from 2 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

2 sources

Left 50%

Center 0%

Right 50%


Topics:

Business · 2

Related coverage for "CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?": The Motley Fool — If You'd Invested $1,500 in Micron Stock 1 Year Ago, Here's How Much You'd Have Today. Seeking Alpha — Dynex Capital Preferreds: Call Risk Reduces The Investment Appeal